Evidence map›Paper›PMID 35160018›Full record

ArticleJournal of clinical medicine2022

Sustained Improvements in Antimicrobial Therapy and Clinical Outcomes following a Pharmacist-Led Antimicrobial Stewardship Intervention: Uncontrolled Before-After Study.

Atsushi Uda, Kei Ebisawa, Hitomi Sakon, Mari Kusuki, Rie Izuta, Mariko Yahata, Ikuko Yano, Takayuki Miyara

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Pharmacist-driven antimicrobial stewardship: evolving roles in clinical practice.Journal of pharmaceutical health care and sciences · 2026
    Review
  2. Article
  3. Article
  4. Retrospective, single-center assessment of a pharmacist-led anti-methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. The role of the clinical pharmacist in antimicrobial stewardship in Asia: A review.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Atsushi UdaDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Kei EbisawaDepartment of Infectious Disease, Kobe University Hospital, Kobe 650-0017, Japan.
Hitomi SakonDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Mari KusukiDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Rie IzutaDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Mariko YahataDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.
Ikuko YanoDepartment of Pharmacy, Kobe University Hospital, Kobe 650-0017, Japan.
Takayuki MiyaraDepartment of Infection Control and Prevention, Kobe University Hospital, Kobe 650-0017, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our antimicrobial pharmacist-led intervention included: (a) a structured review of antibiotic prescriptions; (b) educating prescribers on antimicrobial therapy; (c) monthly reporting of department-level rates of blood sampling for culture. Daily review began in May 2018 and was discontinued after 10 months; however, the other interventions were conducted throughout the study period. This study aimed to evaluate the sustained impact of pharmacist's interventions on antimicrobial therapy and clinical outcomes between the baseline (May-December 2017), intervention (May-December 2018), and post-intervention (May-December 2019) periods. The rate of blood culture collections before starting antipseudomonal agent therapy was significantly increased from the baseline to post-intervention periods (71% vs. 85%,

Indexed as

antibiotic useantimicrobial stewardshipblood culture collectionclinical outcomede-escalation therapyinfectious disease pharmacist

Identifiers

PMID35160018
PMCPMC8837014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.